drug
(budesonide + formoterol fumarate)
Marketedupdated 3mo agoby AstraZeneca Pharmaceuticals LP
Approvedcommunity read0 votes
indications
investigational
COPDAsthma
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
May 28, 2030
~3.8 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (2)
- May 28, 2030formulationUS 107167533.8y
- May 28, 2030method-of-use (U-3203)US 94150093.8y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that